ECG abnormalities in tricyclic antidepressant ingestion.
The tricyclic antidepressant (TCA) agents are recognized for their potentially lethal cardiovascular and neurological effects in poisoned patients. The 12-lead electrocardiogram (ECG) has emerged as a popular bedside tool in the evaluation of TCA toxicity. Although the history and physical examination play a key role in the assessment of the patient with potential TCA poisoning, the presence or absence of features of the TCA toxidrome are not sufficient to detect or exclude toxicity from this class of drugs. A variety of ECG findings occur with TCA toxicity. Aside from the sinus tachycardia due principally to anticholinergic effects, TCA-toxic changes seen on the ECG are attributable primarily to the sodium channel blockade caused by these agents. The majority of patients at significant risk for developing cardiac or neurological toxicity will have a QRS complex greater than 0.10 seconds or a rightward shift of the terminal 40 ms of the frontal plane QRS complex vector. The majority of these patients will also display these changes early in their emergency department stay. However, the appearance of these findings, either alone or in combination, does not mean the patient will develop significant cardiac or neurological toxicity. The ECG can neither unequivocally rule in nor rule out impending toxicity; recognizing these limitations, the emergency physician can use this bedside tool in combination with other clinical data during the assessment of the poisoned patient.
Harrigan
R A
RA
Department of Emergency Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
Brady
W J
WJ
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000506:poisoning; D000328:Adult; D000639:Amitriptyline / Q000506:poisoning; D000929:Antidepressive Agents, Tricyclic / Q000506:poisoning*; D000931:Antidotes / Q000627:therapeutic use; D001146:Arrhythmia, Sinus / Q000139:chemically induced; D002606:Charcoal / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000506:poisoning; D004316:Doxepin / Q000506:poisoning; D062787:Drug Overdose; D004562:Electrocardiography / Q000187:drug effects*; D005260:Female; D006801:Humans; D019095:Point-of-Care Systems; D017693:Sodium Bicarbonate / Q000627:therapeutic use; D026941:Sodium Channel Blockers; D016060:Sorption Detoxification; D013610:Tachycardia / Q000139:chemically induced
D018759:Adrenergic Uptake Inhibitors; D000929:Antidepressive Agents, Tricyclic; D000931:Antidotes; D018680:Cholinergic Antagonists; D026941:Sodium Channel Blockers; D002606:Charcoal; D004316:Doxepin; D000639:Amitriptyline; D017693:Sodium Bicarbonate